There is conflicting advice noted between the differing documentation, supporting the device. For example:Contraindications (from Manual G1-IP68)The Hilo Band IS NOT INTENDED to be used :on patients suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including tachycardia(heart rate at rest greater than 120bpm) and atrial fibrillation;on patients suffering from pathologies that systematically reduce peripheral perfusion including Raynaud’s disease, diabetes, renal dysfunctions(eGFR less than 60mL - min - 1.73 m2), hyper or hypothyroidism, pheochromocytoma or arteriovenous fistula;on pregnant women;on damaged - injured skin;on patients below 21 y.o. and above 85 y.o.vs(Website - support page - contraindications)The Hilo Products are NOT INTENDED to be used:on patients suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including resting tachycardia (heart rate at rest greater than 120bpm) and atrial fibrillation; on patients suffering from pathologies that systematically reduce peripheral perfusion including Raynaud’s disease, diabetes, renal dysfunctions (eGFR less than 30mL - min - 1.73 m2), untreated hyper or hypothyroidism, pheochromocytoma, or arteriovenous fistula; on pregnant women; amputated upper limb; on patients below 21 years old and above 85 years oldWhen seeking clarification, especially with the eGFR and hyper - hypothyroidism differences - the Web chat took too long. The initial response just listed the contraindications noted on the web page as opposed to the manuals. So still waiting for a response seeking clarification.I'm not saying that the Customer support is bad, but it is slow. The band looks great and can be so useful, but if it is providing inaccurate information (due to not being suitable for an individual, but results being relied upon by that same individual), could reduce reliability and potentially be dangerous.The website and manuals should contain or relay the same details for contraindications of use.
Claim your business profile now and gain access to all features and respond to customer reviews.
Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.
Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.See more
